Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Nephros, Inc. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

165 daysmedian FDA review time
296 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K161304EndoPur FilterNephros, Inc.2017-03-022960
K161467HydraGuard 10 UltraFilterNephros, Inc.2016-12-222090
K153084Nephros S100Nephros, Inc.2016-04-081650
K141731NEPHROS DSU-H, NEPHROS SSU-HNephros, Inc.2014-10-241190
K112314NEPHROS OLPUR H2H HEMODIAFILTRATION (HDF) MODULE AND OLPUR MNephros, Inc.2012-04-272600
K110285NEPHROS DSU FILTER, NEPHROS MSU FILTER, NEPHROS SSU FILTERNephros, Inc.2011-07-141640
K090885NEPHROS, INC., DSU DUAL STAGE ULTRAFILTERNephros, Inc.2009-06-29900
K050603OLPUR DIALYZER, MODEL HD 190Nephros, Inc.2005-06-09920

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda